John is responsible for providing medical leadership and oversight for Bionical Emas’ clinical development studies, Early Access Programs and corporate medical matters.
John is a board certified/specialist accredited physician trained in London and Oxford university hospitals, with wide clinical experience in the care of patients, including those with cancer, and respiratory, infectious and rare diseases. He has over 25 years of global drug development experience in senior medical and R&D roles (CMO, SVP, Exec VP), in and advising la
